Venus Remedies’ R3SET Takes Strategic Leap into Wellness with Holistic Health Innovations

December 21, 2023
  • The company has unveiled a significant transformation of its consumer healthcare division, R3SET, marking a strategic foray into the wellness arena
  • This expansion brings to the forefront a diverse range of products tailored to meet a spectrum of healthcare and wellness needs, including pain relief, mental well-being, restful sleep and detoxification

 India

healthysoch

New Delhi, December 21, 2023:

Venus Remedies Limited, a pioneer in pharmaceutical R&D, today unveiled a significant transformation of its consumer healthcare division, R3SET. This strategic pivot marks R3SET’s foray into the wellness arena, coupled with the expansion of its pain management portfolio, showcasing the company’s holistic approach to wellness solutions.

According to recent data from Euromonitor, the Indian Consumer Healthcare market was valued at Rs 42,392 crore in 2023 and is projected to grow by a 4-5% CAGR till 2028.

“R3SET’s entry into the wellness domain is not just an expansion; it’s a reflection of our ethos that wellness should be an intrinsic part of everyday life. Our products and brand identity are designed to nurture wellness as a daily ritual, seamlessly fitting into the consumer’s lifestyle,” stated Mr. Saransh Chaudhary, President, Consumer Healthcare, Venus Remedies Limited. “This strategic move is a testament to our commitment to making wellness an accessible, everyday experience for our consumers,” he added.

The launch of R3SET Detox Candies, crafted with a blend of natural herbs such as Kalmegh, Punarnava, Daru Haldi, Manjistha, and Guduchi, positions the brand at the forefront of the wellness journey. These candies serve as effective liver detoxifiers and stress relievers, offering consumers a ‘Dose of Good’ with each bite. Available in two convenient packaging options – a 30-candy box and a 60-candy box – they cater to the growing demand for healthy products.

Simultaneously, R3SET is fortifying its pain-management portfolio with the introduction of the R3SET Ultra Potent Gel. This advanced gel, filled in a strikingly luxurious ceramic jar in 100g packing with twice the effectiveness of its predecessor, reflects R3SET’s commitment to delivering long-term healing solutions for body pain management. Wanting the users to sustainably use and not throw away the jar, the brand will be launching a 300g refill option for the R3SET Ultra Potent Gel, providing customers with a convenient and cost-effective way to replenish their supply, giving back a “Dose of Good” to the planet at the same time.

The brand’s comprehensive pain-reliever product range, including gels, emulsions, sprays and tablets, incorporates natural enhancements and nano-tech formulations, showcasing the fusion of cutting-edge technology with the power of natural painkillers.

R3SET’s commitment extends to environmental stewardship, featuring eco-friendly packaging and collaborations with Forest Stewardship Council (FSC)-certified vendors. The innovative edge of R3SET’s products, rooted in Venus Medicine Research Centre’s extensive research and development, differentiates the brand in the competitive D2C wellness landscape.

R3SET’s strategic shift, bolstered by a transformative rebranding initiative, demonstrates the brand’s dedication to becoming a key player in the holistic healthcare and wellness sector. Along with the refreshed product portfolio, the brand unveiled its new identity, designed to deliver a profound “Dose of Good” at every stage of a consumer’s interaction with the brand, be it through the website, social media, product packaging or the product itself. The rebranding aims to cultivate a community where wellness is seamlessly integrated into daily life.

healthysoch

Stay informed with the latest news from HealthySoch. Sign up today for exclusive insights and updates!

We promise we never spam!

Leave a Reply

Your email address will not be published.

Columnists

HealthySoch

Don't Miss

Vaccination efforts need to be intensified in India

Measles and rubella in particular need to be curtailed New

India’s Cumulative COVID-19 Vaccination Coverage exceeds 104.04 Cr

New Delhi, October 28, 2021: With the administration of 49,09,254 vaccine doses